A Comparative Evaluation of the Genetic Variant Spectrum in the USH2A Gene in Russian Patients with Isolated and Syndromic Forms of Retinitis Pigmentosa
International Journal of Molecular Sciences · 13.11.2024 · 25 (22) · 12169
DOI: 10.3390/ijms252212169 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.11.2024. Verfasst von Natalya Ogorodova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, Moscow 115522, Russia. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Extracellular Matrix Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pathogenic variants in the USH2A gene are the primary cause of both non-syndromic autosomal recessive inherited retinitis pigmentosa (RP) and the syndromic form, characterized by retinal degeneration and sensorineural hearing loss. This study presents a comparative assessment of the genetic variant spectrum in the USH2A gene among Russian patients in two clinical groups. A retrospective analysis was conducted on massive parallel panel sequencing data from 2415 blood samples of unrelated patients suspected of having hereditary retinal diseases. The copy number of USH2A exons was determined using the quantitative MLPA method with the MRC-Holland SALSA MLPA kit. Biallelic pathogenic and likely pathogenic variants in the USH2A gene were identified in 69 patients (8.7%). In the group of patients with isolated hereditary RP (55 patients), the most frequent pathogenic variants were p.(Glu4445_Ser4449delinsAspLeu) (20.9%), p.(Trp3955*) (15.5%), and p.(Cys934Trp) (5.5%). In patients with the syndromic form (14 patients), the most frequent variants were p.(Trp3955*) (35.7%) and c.8682-9A>G (17.9%). It was found that patients with isolated vision impairment rarely had two “null” variants (17.8%), whereas this was common among patients with both hearing and vision impairment (71.4%) (p ≤ 0.05), explaining the severity of the disease and the earlier onset of clinical symptoms in the syndromic form of RP. Ten previously undescribed loss-of-function variants were identified. The estimated prevalence of USH2A-associated retinal dystrophy in Russia was 1.9 per 100,000 individuals. The obtained data on the differences in the spectra of genetic variants in the USH2A gene in the two studied groups highlight the importance of establishing genotype–phenotype correlations and predicting disease severity, aiming at potential early cochlear implantation and selection of target therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Medical Genetics, Moscow 115522, Russia.
ORCID-Profile: Anna Stepanova, Vitaly Kadyshev, Olga Ismagilova, Olga Shchagina
Zitieren
APA
Ogorodova, N., Stepanova, A., Kadyshev, V., Kuznetsova, S., Ismagilova, O., Chukhrova, A., Polyakov, A., Kutsev, S., & Shchagina, O. (2024). A Comparative Evaluation of the Genetic Variant Spectrum in the USH2A Gene in Russian Patients with Isolated and Syndromic Forms of Retinitis Pigmentosa. International Journal of Molecular Sciences, 25(22), 12169. https://doi.org/10.3390/ijms252212169
Vancouver
Ogorodova N, Stepanova A, Kadyshev V, Kuznetsova S, Ismagilova O, Chukhrova A, et al. A Comparative Evaluation of the Genetic Variant Spectrum in the USH2A Gene in Russian Patients with Isolated and Syndromic Forms of Retinitis Pigmentosa. International Journal of Molecular Sciences. 2024;25(22):12169. doi:10.3390/ijms252212169
BibTeX
@article{Ogorodova2024,
author = {Ogorodova, Natalya and Stepanova, Anna and Kadyshev, Vitaly and Kuznetsova, Svetlana and Ismagilova, Olga and Chukhrova, Alena and Polyakov, Aleksandr and Kutsev, Sergey and Shchagina, Olga},
title = {A Comparative Evaluation of the Genetic Variant Spectrum in the USH2A Gene in Russian Patients with Isolated and Syndromic Forms of Retinitis Pigmentosa},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {22},
pages = {12169},
doi = {10.3390/ijms252212169}
}
EUVIMED